Cancer Horizons logo
Select a Cancer Type:

Lung

Lung Cancer

RELATED ARTICLES

Molecular Genotype Testing May Improve Lung Cancer Outcomes
Molecular Genotype Testing May Improve Lung Cancer Outcomes
Obtaining molecular genotyping results before first-line treatment resulted in better outcomes for patients with non-small cell lung cancer, an expert explained.
ROS1-Positive NSCLC Represents a Targetable Mutation for New Therapies
ROS1-Positive NSCLC Represents a Targetable Mutation for New Therapies
An expert explained what ROS1-positive non-small cell lung cancer is and why it is important to identify mutations like ROS1 through genetic sequencing.
Robotic Lung Cancer Surgery Improves Quality of Life ‘100 Fold’
Robotic Lung Cancer Surgery Improves Quality of Life ‘100 Fold’
An expert discusses how the use of robotic surgery improves the lives of patients with cancer, and looks forward to advancements that may come in 2024 and beyond.
Next-Generation Sequencing Helps ‘Select the Best Treatment’ for Lung Cancer
Next-Generation Sequencing Helps ‘Select the Best Treatment’ for Lung Cancer
Undergoing next-generation sequencing before receiving treatment can benefit patients with lung cancer and their doctors, as one expert told CURE®.
Differences Between Lung Cancer and Pleural Mesothelioma
Differences Between Lung Cancer and Pleural Mesothelioma
Lung cancer and pleural mesothelioma are often confused, so it’s important to understand the key differences between them, including tumor location and treatments.
What is a BRAF Mutation and Why is it Targeted in Lung Cancer Treatment?
What is a BRAF Mutation and Why is it Targeted in Lung Cancer Treatment?
Following the recent FDA approval of Braftovi with Mektovi for some patients with NSCLC and a BRAF V600E mutation, a lung cancer expert explains the science behind the news.
Comparing Small Cell and Non-Small Cell Lung Cancer
Comparing Small Cell and Non-Small Cell Lung Cancer
There are two different types of lung cancer — small cell and non-small cell lung cancer — that behave differently and therefore require different treatments, an expert explained.
Exciting Lung Cancer Advances from 2023
Exciting Lung Cancer Advances from 2023
In honor of World Lung Cancer Day, we took a look back at some of the exciting progress being made in the space.
Immunotherapy Plus Chemo Benefits Patients with NSCLC
Immunotherapy Plus Chemo Benefits Patients with NSCLC
Patients with a history of proton pump inhibitor use and who have NSCLC with a PD-L1 tumor proportion score of 50% or more benefit from immune checkpoint inhibitor plus chemotherapy as treatment.
Immunotherapy May Improve Lung Cancer Outcomes, Reduce Side Effects
Immunotherapy May Improve Lung Cancer Outcomes, Reduce Side Effects
Recent developments in the use of immunotherapy for lung cancer have provided more treatment options for patients while potentially reducing side effect profiles.
Causes of Lung Cancer
Causes of Lung Cancer
Lung cancer is not only caused by smiling – great article on things to look out for
Stage 4 Lung Cancer Survival Rate
Stage 4 Lung Cancer Survival Rate
Affecting all races and genders equally, this indiscriminate beast takes loved ones at a terrifying rate By Kathryn E. Vinson, MS, CCRC From the time
Stage Four Lung Cancer
Stage Four Lung Cancer
Some cancers discriminate – men versus women – senior citizens versus middle-aged adults – race versus race. Some cancers, however, don’t really care who they hit and lung cancer is one of those.